Evaluation of benazepril in cats with heart disease | VETgirl Veterinary Continuing Education Podcasts
VETgirl Veterinary Continuing Education Podcasts
English - January 04, 2021 06:00 - 10 minutes - 9.54 MB - ★★★★★ - 361 ratingsEducation Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
In today's VETgirl online veterinary continuing education podcast, we review the use of benazepril in cats with cardiac disease. Despite a wide variety of medications used to treat heart disease in cats, there is little prospective data to support a definitive benefit with use of any medication in cats with heart disease. Previous data has established a benefit for the use of angiotensin converting enzyme (ACE) inhibitors in humans and dogs with congestive heart failure. But what about cats? Activation of the renin-angiotensin-aldosterone system (RAAS) is a known phenomenon in cats with heart disease. So King et al (and I mean ALL) wanted to evaluate this in a study published in the Journal of Veterinary Internal Medicine in 2019 entitled Evaluation of benazepril in cats with heart disease in a prospective, randomized, blinded, placebo-controlled clinical trial. The authors of this study posited that benazepril, an ACE inhibitor, might provide benefit to cats with heart disease, regardless of type.